Cargando…

Hepatic mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver: a pathologic review

This review highlights two rare entities that are predominantly seen in children: hepatic mesenchymal hamartoma (HMH) and undifferentiated embryonal sarcoma of the liver (UESL). HMH is a benign lesion predominantly seen in the first 2 years of life, while UESL is malignant and usually identified in...

Descripción completa

Detalles Bibliográficos
Autores principales: Martins-Filho, Sebastiao N, Putra, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338921/
https://www.ncbi.nlm.nih.gov/pubmed/32647564
http://dx.doi.org/10.2217/hep-2020-0002
_version_ 1783554784859521024
author Martins-Filho, Sebastiao N
Putra, Juan
author_facet Martins-Filho, Sebastiao N
Putra, Juan
author_sort Martins-Filho, Sebastiao N
collection PubMed
description This review highlights two rare entities that are predominantly seen in children: hepatic mesenchymal hamartoma (HMH) and undifferentiated embryonal sarcoma of the liver (UESL). HMH is a benign lesion predominantly seen in the first 2 years of life, while UESL is malignant and usually identified in patients between 6 and 10 years of age. UESL may arise in the background of HMH, and the association has been supported by similar chromosomal aberrations (19q13.4). The diagnosis of both lesions is primarily based on histologic evaluation, as the clinical and radiological features are not always typical. The clinicopathologic characteristics, pathogenesis, differential diagnoses and treatment for both lesions are discussed.
format Online
Article
Text
id pubmed-7338921
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Future Medicine Ltd
record_format MEDLINE/PubMed
spelling pubmed-73389212020-07-08 Hepatic mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver: a pathologic review Martins-Filho, Sebastiao N Putra, Juan Hepat Oncol Review This review highlights two rare entities that are predominantly seen in children: hepatic mesenchymal hamartoma (HMH) and undifferentiated embryonal sarcoma of the liver (UESL). HMH is a benign lesion predominantly seen in the first 2 years of life, while UESL is malignant and usually identified in patients between 6 and 10 years of age. UESL may arise in the background of HMH, and the association has been supported by similar chromosomal aberrations (19q13.4). The diagnosis of both lesions is primarily based on histologic evaluation, as the clinical and radiological features are not always typical. The clinicopathologic characteristics, pathogenesis, differential diagnoses and treatment for both lesions are discussed. Future Medicine Ltd 2020-04-07 /pmc/articles/PMC7338921/ /pubmed/32647564 http://dx.doi.org/10.2217/hep-2020-0002 Text en © 2020 Juan Putra https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Review
Martins-Filho, Sebastiao N
Putra, Juan
Hepatic mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver: a pathologic review
title Hepatic mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver: a pathologic review
title_full Hepatic mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver: a pathologic review
title_fullStr Hepatic mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver: a pathologic review
title_full_unstemmed Hepatic mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver: a pathologic review
title_short Hepatic mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver: a pathologic review
title_sort hepatic mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver: a pathologic review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338921/
https://www.ncbi.nlm.nih.gov/pubmed/32647564
http://dx.doi.org/10.2217/hep-2020-0002
work_keys_str_mv AT martinsfilhosebastiaon hepaticmesenchymalhamartomaandundifferentiatedembryonalsarcomaoftheliverapathologicreview
AT putrajuan hepaticmesenchymalhamartomaandundifferentiatedembryonalsarcomaoftheliverapathologicreview